Grant Number:	5R00CA126147-05 Interpret this number
Primary Investigator:	Mcmahon, Pamela
Organization:	Massachusetts General Hospital
Project Title:	Developing Approaches for Modeling Genomic and Proteomic Profiles in Lung Cancer
Fiscal Year:	2011

DESCRIPTION (provided by applicant): Despite recent decreases in smoking rates, lung cancer claimed more than 163,000 American lives in 2005. Interest in possible lung cancer screening programs is intense; several large ongoing trials are evaluating imaging technologies to detect early-stage lung cancer. In addition, public and private investment in genomic and proteomic research may add biomarkers to the list of tools for lung cancer screening. Decisions about the appropriate roles of imaging and biomarkers in lung cancer screening programs can be informed by modeling, a formal, transparent way to integrate available data. In the proposed independent phase, I will incorporate genomic and proteomic profiles into the Lung Cancer Policy Model, a comprehensive microsimulation model of lung cancer designed to evaluate the cost, effectiveness, and cost-effectiveness of screening programs. I am an outcomes researcher with experience in developing complex disease simulation models, including the natural history model at the core of the Lung Cancer Policy Model. My long term research agenda is to develop methods and approaches to making disease simulation models more robust and useful to decision makers. Specifically, future approaches for cancer screening, treatment, and surveillance promise to be increasingly tailored to the individual patient. Modeling cancer interventions will require much more detail on individual characteristics and clinical algorithms than is now typical in disease simulation models. The site of the proposed study, the Institute for Technology Assessment (ITA) at Massachusetts General Hospital, offers a rich combination of facilities, expertise, and mentorship. The proposed Sponsor, G. Scott Gazelle, MD MPH PhD, became my primary mentor when I joined the ITA in 1998 as a research assistant, and recently chaired my doctoral dissertation committee. We have established a comfortable and productive work environment and have developed a mentoring plan that will allow me to complete my transition to an independent researcher role. Protected time for coursework, meetings with an Advisory Committee of clinical and modeling experts, and completion of ongoing analyses involving the Lung Cancer Policy Model will position me appropriately to undertake the proposed research and apply for an independent research award.




Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy.
Authors: Bornstein R. , James K. , Stokes J. , Park K.Y. , Kayser E.B. , Snell J. , Bard A. , Chen Y. , Kalume F. , Johnson S.C. .
Source: Neurobiology Of Disease, 2022 02; 163, p. 105594.
EPub date: 2021-12-20 00:00:00.0.
PMID: 34933094
Related Citations

Combined Biomarker and Computed Tomography Screening Strategies for Lung Cancer: Projections of Health and Economic Tradeoffs in the US Population.
Authors: Kong C.Y. , Sheehan D.F. , McMahon P.M. , Gazelle G.S. , Pandharipande P. .
Source: Mdm Policy & Practice, 2016 Jul-Dec; 1(1), .
EPub date: 2016-07-07 00:00:00.0.
PMID: 30148212
Related Citations

Personalizing Annual Lung Cancer Screening For Patients With Chronic Obstructive Pulmonary Disease: A Decision Analysis
Authors: Lowry K.P. , Gazelle G.S. , Gilmore M.E. , Johanson C. , Munshi V. , Choi S.E. , Tramontano A.C. , Kong C.Y. , McMahon P.M. .
Source: Cancer, 2015-05-15 00:00:00.0; 121(10), p. 1556-62.
PMID: 25652107
Related Citations

Microsimulation Model Predicts Survival Benefit Of Radiofrequency Ablation And Stereotactic Body Radiotherapy Versus Radiotherapy For Treating Inoperable Stage I Non-small Cell Lung Cancer
Authors: Tramontano A.C. , Cipriano L.E. , Kong C.Y. , Shepard J.A. , Lanuti M. , Gazelle G.S. , McMahon P.M. .
Source: Ajr. American Journal Of Roentgenology, 2013 May; 200(5), p. 1020-7.
PMID: 23617484
Related Citations

Cost-effectiveness Of Alternating Magnetic Resonance Imaging And Digital Mammography Screening In Brca1 And Brca2 Gene Mutation Carriers
Authors: Cott Chubiz J.E. , Lee J.M. , Gilmore M.E. , Kong C.Y. , Lowry K.P. , Halpern E.F. , McMahon P.M. , Ryan P.D. , Gazelle G.S. .
Source: Cancer, 2013-03-15 00:00:00.0; 119(6), p. 1266-76.
PMID: 23184400
Related Citations

Chapter 9: The Mgh-hms Lung Cancer Policy Model: Tobacco Control Versus Screening
Authors: McMahon P.M. , Kong C.Y. , Johnson B.E. , Weinstein M.C. , Weeks J.C. , Tramontano A.C. , Cipriano L.E. , Bouzan C. , Gazelle G.S. .
Source: Risk Analysis : An Official Publication Of The Society For Risk Analysis, 2012 Jul; 32 Suppl 1, p. S117-24.
PMID: 22882882
Related Citations

Chapter 13: Cisnet Lung Models: Comparison Of Model Assumptions And Model Structures
Authors: McMahon P.M. , Hazelton W.D. , Kimmel M. , Clarke L.D. .
Source: Risk Analysis : An Official Publication Of The Society For Risk Analysis, 2012 Jul; 32 Suppl 1, p. S166-78.
PMID: 22882887
Related Citations

Annual Screening Strategies In Brca1 And Brca2 Gene Mutation Carriers: A Comparative Effectiveness Analysis
Authors: Lowry K.P. , Lee J.M. , Kong C.Y. , McMahon P.M. , Gilmore M.E. , Cott Chubiz J.E. , Pisano E.D. , Gatsonis C. , Ryan P.D. , Ozanne E.M. , et al. .
Source: Cancer, 2012-04-15 00:00:00.0; 118(8), p. 2021-30.
PMID: 21935911
Related Citations

Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000.
Authors: Moolgavkar S.H. , Holford T.R. , Levy D.T. , Kong C.Y. , Foy M. , Clarke L. , Jeon J. , Hazelton W.D. , Meza R. , Schultz F. , et al. .
Source: Journal Of The National Cancer Institute, 2012-04-04 00:00:00.0; 104(7), p. 541-8.
EPub date: 2012-04-04 00:00:00.0.
PMID: 22423009
Related Citations

Using Radiation Risk Models In Cancer Screening Simulations: Important Assumptions And Effects On Outcome Projections
Authors: Kong C.Y. , Lee J.M. , McMahon P.M. , Lowry K.P. , Omer Z.B. , Eisenberg J.D. , Pandharipande P.V. , Gazelle G.S. .
Source: Radiology, 2012 Mar; 262(3), p. 977-84.
PMID: 22357897
Related Citations

Cost-effectiveness Of Computed Tomography Screening For Lung Cancer In The United States
Authors: McMahon P.M. , Kong C.Y. , Bouzan C. , Weinstein M.C. , Cipriano L.E. , Tramontano A.C. , Johnson B.E. , Weeks J.C. , Gazelle G.S. .
Source: Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer, 2011 Nov; 6(11), p. 1841-8.
PMID: 21892105
Related Citations

The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.
Authors: Kong C.Y. , Nattinger K.J. , Hayeck T.J. , Omer Z.B. , Wang Y.C. , Spechler S.J. , McMahon P.M. , Gazelle G.S. , Hur C. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2011 Nov; 20(11), p. 2450-6.
PMID: 21930957
Related Citations

Lung Cancer Treatment Costs, Including Patient Responsibility, By Disease Stage And Treatment Modality, 1992 To 2003
Authors: Cipriano L.E. , Romanus D. , Earle C.C. , Neville B.A. , Halpern E.F. , Gazelle G.S. , McMahon P.M. .
Source: Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 2011 Jan; 14(1), p. 41-52.
PMID: 21211485
Related Citations

Cost-effectiveness Of Breast Mr Imaging And Screen-film Mammography For Screening Brca1 Gene Mutation Carriers
Authors: Lee J.M. , McMahon P.M. , Kong C.Y. , Kopans D.B. , Ryan P.D. , Ozanne E.M. , Halpern E.F. , Gazelle G.S. .
Source: Radiology, 2010 Mar; 254(3), p. 793-800.
PMID: 20177093
Related Citations

Calibration Of Disease Simulation Model Using An Engineering Approach
Authors: Kong C.Y. , McMahon P.M. , Gazelle G.S. .
Source: Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 2009 Jun; 12(4), p. 521-9.
PMID: 19900254
Related Citations

Calibration Methods Used In Cancer Simulation Models And Suggested Reporting Guidelines
Authors: Stout N.K. , Knudsen A.B. , Kong C.Y. , McMahon P.M. , Gazelle G.S. .
Source: Pharmacoeconomics, 2009; 27(7), p. 533-45.
PMID: 19663525
Related Citations

Adopting Helical Ct Screening For Lung Cancer: Potential Health Consequences During A 15-year Period
Authors: McMahon P.M. , Kong C.Y. , Weinstein M.C. , Tramontano A.C. , Cipriano L.E. , Johnson B.E. , Weeks J.C. , Gazelle G.S. .
Source: Cancer, 2008-12-15 00:00:00.0; 113(12), p. 3440-9.
PMID: 18988293
Related Citations

Estimating Long-term Effectiveness Of Lung Cancer Screening In The Mayo Ct Screening Study
Authors: McMahon P.M. , Kong C.Y. , Johnson B.E. , Weinstein M.C. , Weeks J.C. , Kuntz K.M. , Shepard J.A. , Swensen S.J. , Gazelle G.S. .
Source: Radiology, 2008 Jul; 248(1), p. 278-87.
PMID: 18458247
Related Citations